Coherus Oncology Inc Asset Turnover Ratio (CHRS), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Coherus Oncology inc   (NASDAQ: CHRS)
 

Coherus Oncology Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Coherus Oncology Inc asset turnover ratio, the ability of Coherus Oncology Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.24 in the third quarter (Sep 30 2026), yet the ratio remained below the average, as CHRS's position remain challenging.

Within sector 40 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 3069 to 3106.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CHRS Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change -66.87 % -52.22 % -28.31 % -43.04 % 2.28 %
Y / Y Revenue Change 23.36 % 39.53 % 61.99 % -76.46 % -83.65 %
Asset Turnover Ratio (TTM) 0.24 0.16 0.13 0.11 0.19
CHRS's Total Ranking # 3106 # 3069 # 2820 # 3047 #
Seq. Asset Change -18.51 % -21.07 % 2.97 % -49.98 % 17.53 %
Seq. Revenue Change -0.23 % 16.22 % -3.44 % 10.17 % 12.84 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 41
Healthcare Sector # 443
Overall Market # 3106

Asset Turnover Ratio Statistics
High Average Low
1.22 0.49 0.11
(Dec 31 2019)   (Dec 31 2025)




CHRS Company Profile • Back to CHRS Efficiency Comparisons • Compare CHRS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Encompass Health Corporation  0.86 $ 6,338.100  Millions$ 7,356.725  Millions
Alpha Pro Tech Ltd   0.86 $ 64.940  Millions$ 75.551  Millions
Carlisle Companies Incorporated  0.85 $ 5,213.500  Millions$ 6,129.300  Millions
Alnylam Pharmaceuticals Inc   0.85 $ 5,013.242  Millions$ 5,912.330  Millions
Trisalus Life Sciences Inc   0.84 $ 47.397  Millions$ 56.580  Millions
West Pharmaceutical Services Inc   0.82 $ 3,397.100  Millions$ 4,129.225  Millions
Protalix Biotherapeutics inc   0.82 $ 84.693  Millions$ 103.315  Millions
Incyte Corporation  0.82 $ 6,010.754  Millions$ 7,364.247  Millions
Penumbra Inc  0.81 $ 1,560.334  Millions$ 1,931.196  Millions
Davita Inc   0.80 $ 14,167.545  Millions$ 17,626.367  Millions
Dexcom Inc   0.80 $ 5,104.900  Millions$ 6,416.825  Millions
Amneal Pharmaceuticals Inc   0.79 $ 3,196.184  Millions$ 4,065.517  Millions
Axogen inc   0.78 $ 266.926  Millions$ 341.594  Millions
Labcorp Holdings Inc   0.78 $ 14,594.500  Millions$ 18,734.175  Millions
Iradimed Corporation  0.78 $ 89.340  Millions$ 114.803  Millions
Alector Inc   0.77 $ 173.469  Millions$ 225.446  Millions
Lifestance Health Group Inc   0.77 $ 1,676.889  Millions$ 2,179.399  Millions
Pulmonx Corporation  0.75 $ 89.176  Millions$ 118.550  Millions
Beone Medicines Ltd   0.74 $ 6,606.279  Millions$ 8,948.433  Millions
Arbutus Biopharma Corp  0.74 $ 181.490  Millions$ 246.376  Millions
Msa Safety Inc  0.73 $ 2,015.730  Millions$ 2,749.546  Millions
Adapthealth Corp   0.73 $ 3,152.043  Millions$ 4,320.541  Millions
Neurocrine Biosciences Inc   0.72 $ 3,701.700  Millions$ 5,131.050  Millions
Tenet Healthcare Corp  0.72 $ 22,154.000  Millions$ 30,787.000  Millions
Strata Critical Medical Inc   0.72 $ 236.425  Millions$ 328.668  Millions
Acadia Pharmaceuticals Inc   0.72 $ 1,202.301  Millions$ 1,676.619  Millions
Gossamer Bio Inc   0.71 $ 78.423  Millions$ 110.588  Millions
Quest Diagnostics Inc  0.71 $ 11,841.000  Millions$ 16,764.500  Millions
Mirum Pharmaceuticals Inc   0.71 $ 670.778  Millions$ 951.331  Millions
Ani Pharmaceuticals Inc  0.70 $ 1,041.343  Millions$ 1,481.030  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.